Author

Yu Tao

Washington University in St. LouisORCID 0000-0001-8204-432XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

David DeNardo· 1 shared Douglas Faget· 1 shared Edward CamposiD· 1 shared Ganesh Raut· 1 shared Jingqin LuoiD· 1 shared Radhika MishraiD· 1 shared Renata Ferreira· 1 shared Sheila A. StewartiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

David DeNardo

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintOct 28, 2026

Targeting MK2-Driven Stromal Senescence Sensitizes Breast Cancer Bone Metastasis to Immunotherapy

Renata Ferreira, Douglas Faget, Radhika Mishra…·Sheila A. Stewart

This study identifies senescent cancer-associated fibroblasts (senCAFs) driven by MK2 that promote immunosuppression in bone metastases and shows that combining MK2 inhibition with OX40 agonists enhances immunotherapy efficacy.

DOI 10.64898/2026.10.26.761990

humanbulk RNA-seq

𝕏 PostBluesky